Relx plc (REL)

Sector:

IT Services

Index:

FTSE 100

3,990.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 4,135.00
  • 52 Week Low: 3,450.00
  • Currency: UK Pounds
  • Shares Issued: 1,835.11m
  • Volume: 2,081,586
  • Market Cap: £73,221m
  • RiskGrade: 128
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Relx confirms guidance after 'strong' start to the year

By Abigail Townsend

Date: Thursday 24 Apr 2025

LONDON (ShareCast) - (Sharecast News) - Relx reiterated its full-year outlook on Thursday, after the analytics provider said the year had got off to a "strong" start.
The global firm, which provides information-based analytics and decision tools to professionals businesses, said underlying revenues had grown in all four of its divisions.

In risk, which accounts for 34% of group sales, strong revenue growth had been driven largely by financial crime compliance and by digital fraud and identity.

In its scientific, technical and medical unit, Relx's second-biggest division, the jump in revenues was attributed to "the evolution of the business mix".

Relx said: "The full-year outlook is unchanged.

"We continue to see positive momentum across the group, and we expect another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share on a constant currency basis."

As at 0830 BST, the blue chip's London-listed shares were up 1% at 3,965p. The company, which employs around 36,000 people across more than 180 countries, is also listed in Amsterdam and New York.

Relx, formerly known as Reed Elsevier, was updating investors ahead of its annual general meeting. Its year end is 31 December 2025.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Reed Elsevier Market Data

Currency UK Pounds
Share Price 3,990.00p
Change Today 1.00p
% Change 0.03 %
52 Week High 4,135.00
52 Week Low 3,450.00
Volume 2,081,586
Shares Issued 1,835.11m
Market Cap £73,221m
Beta 0.00
RiskGrade 128

Reed Elsevier Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.43% below the market average99.43% below the market average99.43% below the market average99.43% below the market average99.43% below the market average
92.41% below the sector average92.41% below the sector average92.41% below the sector average92.41% below the sector average92.41% below the sector average
Price Trend
56.73% above the market average56.73% above the market average56.73% above the market average56.73% above the market average56.73% above the market average
63.86% above the sector average63.86% above the sector average63.86% above the sector average63.86% above the sector average63.86% above the sector average
Income
93.11% below the market average93.11% below the market average93.11% below the market average93.11% below the market average93.11% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average
Growth
14.38% above the market average14.38% above the market average14.38% above the market average14.38% above the market average14.38% above the market average
22.08% below the sector average22.08% below the sector average22.08% below the sector average22.08% below the sector average22.08% below the sector average

What The Brokers Say

Strong Buy 4
Buy 8
Neutral 4
Sell 0
Strong Sell 0
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reed Elsevier Dividends

  Latest Previous
  Final Interim
Ex-Div 08-May-25 01-Aug-24
Paid 19-Jun-25 05-Sep-24
Amount 44.80p 18.20p

Trades for 17-Jul-2025

Time Volume / Share Price
15:28 573 @ 3,989.00p
15:12 5 @ 3,985.00p
16:46 125,400 @ 3,992.23p
16:35 373 @ 3,990.00p
16:35 344 @ 3,990.00p

Reed Elsevier Key Personnel

CEO Erik Engstrom
CFO N L Luff
Chair Paul Walker

Top of Page